March 7, 20214 yr On 3/5/2021 at 2:04 PM, EaglesRocker97 said: Let's be honest, this is like the worst time in human history to be having kids. Yeah, sucks to have all this modern medicine and technology. Put us back in the 1700 sans plumbing, vaccines and CocoMelon. Things were much easier then.
March 7, 20214 yr 2 minutes ago, Paul852 said: Yeah, sucks to have all this modern medicine and technology. Put us back in the 1700 sans plumbing, vaccines and CocoMelon. Things were much easier then. It at least made sense from an economic perspective to have kids, especially considering the country was like 90% farmers. ROI was much better
March 7, 20214 yr 15 minutes ago, Paul852 said: Yeah, sucks to have all this modern medicine and technology. Put us back in the 1700 sans plumbing, vaccines and CocoMelon. Things were much easier then. Then you meet this generation of kids, and you realize... Today’s kids suck.
March 7, 20214 yr 36 minutes ago, vikas83 said: Then you meet this generation of kids, and you realize... Today’s kids suck. Said every generation before yours
March 7, 20214 yr 1 hour ago, vikas83 said: Don’t waste your energy on him. He’s trolling with a very old, tired and unfunny shtick because be desperately needs attention, even from strangers on the internet. Not Trolling
March 7, 20214 yr 1 hour ago, Tweek said: I had Pfizer - first shot for me, I felt like crap within 2 hours of getting it and was very tired and groggy for about 36 hours after. Had the second shot this past Monday. Felt fine Monday night but woke up middle of night with severe chills. Would go from multiple layers needed to warm up to sweating all over. I slept all day Tuesday and most of Wednesday. Still felt crappy Thursday, Friday felt more normal. Sounds like I had more of the worst case. Have family members who got second shot and had no issues outside slight tired. My wife had her first dose of the Pfizer shot last week and ended up feeling fine except for a slightly sore arm at the injection site. But just be the luck of the draw.
March 7, 20214 yr 4 hours ago, paco said: Where are you seeing that? Because according to worldometers they have plateaued (dropping slightly), not risen. Same place, I checked a week or so ago and it was less than 50,000, then yesterday it was over 68,000 , but even 50,000 is ridiculously high, the CDC wants it to be near zero for life to get back to their version of normal, which by the way is the way things are now, they don't want life like it used to be
March 7, 20214 yr A new possible medication to treat coronavirus-positive patients could be enough to turn the pandemic on its head, Fox News medical contributor Dr. Marc Siegel revealed Sunday on "Fox & Friends Weekend." First-stage testing of the experimental COVID-19 pill called Molnupiravir, by Merck and Ridgeback Biotherapeutics, showed promising signs of effectiveness in reducing the virus in patients. "It may be the holy grail on this because it was just studied in phase two trials and it literally stopped the virus in its tracks," he explained. "And there wasn't any virus found in the patients that were studied." https://www.foxnews.com/health/covid-19-pill-preliminary-testing-dr-marc-siegel
March 7, 20214 yr 8 minutes ago, NVeagle said: A new possible medication to treat coronavirus-positive patients could be enough to turn the pandemic on its head, Fox News medical contributor Dr. Marc Siegel revealed Sunday on "Fox & Friends Weekend." First-stage testing of the experimental COVID-19 pill called Molnupiravir, by Merck and Ridgeback Biotherapeutics, showed promising signs of effectiveness in reducing the virus in patients. "It may be the holy grail on this because it was just studied in phase two trials and it literally stopped the virus in its tracks," he explained. "And there wasn't any virus found in the patients that were studied." https://www.foxnews.com/health/covid-19-pill-preliminary-testing-dr-marc-siegel Isn't this the same guy that said hydroxy whatever was a breakthrough?
March 7, 20214 yr 15 minutes ago, Joe Shades 73 said: Isn't this the same guy that said hydroxy whatever was a breakthrough? I know he argued that it's approval being revoked by the FDA was political to get back at Trump at one point, but not sure if he softened his stance later on or not. He also perpetuated the "Hillary Clinton has a serious medical disease" BS during the 2016 election, and then ironically conducted the "Person, Woman, Man, Camera, TV" interview with Trump after his cognitive evaluation leaked.
March 7, 20214 yr 39 minutes ago, Joe Shades 73 said: Isn't this the same guy that said hydroxy whatever was a breakthrough? First-stage testing of the experimental COVID-19 pill called Molnupiravir, by Merck and Ridgeback Biotherapeutics, showed promising signs of effectiveness in reducing the virus in patients.
March 7, 20214 yr 45 minutes ago, Joe Shades 73 said: Isn't this the same guy that said hydroxy whatever was a breakthrough? News Filter Results Return to Search Treatment with Hydroxychloroquine Cut Death Rate Significantly in COVID-19 Patients, Henry Ford Health System Study Shows July 02, 2020 DETROIT – Treatment with hydroxychloroquine cut the death rate significantly in sick patients hospitalized with COVID-19 – and without heart-related side-effects, according to a new study published by Henry Ford Health System. In a large-scale retrospective analysis of 2,541 patients hospitalized between March 10 and May 2, 2020 across the system’s six hospitals, the study found 13% of those treated with hydroxychloroquine alone died compared to 26.4% not treated with hydroxychloroquine. None of the patients had documented serious heart abnormalities; however, patients were monitored for a heart condition routinely pointed to as a reason to avoid the drug as a treatment for COVID-19. The study was published today in the International Journal of Infectious Diseases, the peer-reviewed, open-access online publication of the International Society of Infectious Diseases (ISID.org). Patients treated with hydroxychloroquine at Henry Ford met specific protocol criteria as outlined by the hospital system’s Division of Infectious Diseases. The vast majority received the drug soon after admission; 82% within 24 hours and 91% within 48 hours of admission. All patients in the study were 18 or over with a median age of 64 years; 51% were men and 56% African American. "The findings have been highly analyzed and peer-reviewed,” said Dr. Marcus Zervos, division head of Infectious Disease for Henry Ford Health System, who co-authored the study with Henry Ford epidemiologist Samia Arshad. "We attribute our findings that differ from other studies to early treatment, and part of a combination of interventions that were done in supportive care of patients, including careful cardiac monitoring. Our dosing also differed from other studies not showing a benefit of the drug. And other studies are either not peer reviewed, have limited numbers of patients, different patient populations or other differences from our patients.” Zervos said the potential for a surge in the fall or sooner, and infections continuing worldwide, show an urgency to identifying inexpensive and effective therapies and preventions. "We’re glad to add to the scientific knowledge base on the role and how best to use therapies as we work around the world to provide insight,” he said. "Considered in the context of current studies on the use of hydroxychloroquine for COVID-19, our results suggest that the drug may have an important role to play in reducing COVID-19 mortality.” Read "Hydroxychloroquine: An Open Letter to the Community & Beyond" here The study also found those treated with azithromycin alone or a combination of hydroxychloroquine and azithromycin also fared slightly better than those not treated with the drugs, according to the Henry Ford data. The analysis found 22.4% of those treated only with azithromycin died, and 20.1% treated with a combination of azithromycin and hydroxychloroquine died, compared to 26.4% of patients dying who were not treated with either medication. "Our analysis shows that using hydroxychloroquine helped save lives,” said neurosurgeon Dr. Steven Kalkanis, CEO, Henry Ford Medical Group and Senior Vice President and Chief Academic Officer of Henry Ford Health System. "As doctors and scientists, we look to the data for insight. And the data here is clear that there was benefit to using the drug as a treatment for sick, hospitalized patients.” https://www.henryford.com/news/2020/07/hydro-treatment-study
March 7, 20214 yr 38 minutes ago, NVeagle said: News Filter Results Return to Search Treatment with Hydroxychloroquine Cut Death Rate Significantly in COVID-19 Patients, Henry Ford Health System Study Shows July 02, 2020 DETROIT – Treatment with hydroxychloroquine cut the death rate significantly in sick patients hospitalized with COVID-19 – and without heart-related side-effects, according to a new study published by Henry Ford Health System. In a large-scale retrospective analysis of 2,541 patients hospitalized between March 10 and May 2, 2020 across the system’s six hospitals, the study found 13% of those treated with hydroxychloroquine alone died compared to 26.4% not treated with hydroxychloroquine. None of the patients had documented serious heart abnormalities; however, patients were monitored for a heart condition routinely pointed to as a reason to avoid the drug as a treatment for COVID-19. The study was published today in the International Journal of Infectious Diseases, the peer-reviewed, open-access online publication of the International Society of Infectious Diseases (ISID.org). Patients treated with hydroxychloroquine at Henry Ford met specific protocol criteria as outlined by the hospital system’s Division of Infectious Diseases. The vast majority received the drug soon after admission; 82% within 24 hours and 91% within 48 hours of admission. All patients in the study were 18 or over with a median age of 64 years; 51% were men and 56% African American. "The findings have been highly analyzed and peer-reviewed,” said Dr. Marcus Zervos, division head of Infectious Disease for Henry Ford Health System, who co-authored the study with Henry Ford epidemiologist Samia Arshad. "We attribute our findings that differ from other studies to early treatment, and part of a combination of interventions that were done in supportive care of patients, including careful cardiac monitoring. Our dosing also differed from other studies not showing a benefit of the drug. And other studies are either not peer reviewed, have limited numbers of patients, different patient populations or other differences from our patients.” Zervos said the potential for a surge in the fall or sooner, and infections continuing worldwide, show an urgency to identifying inexpensive and effective therapies and preventions. "We’re glad to add to the scientific knowledge base on the role and how best to use therapies as we work around the world to provide insight,” he said. "Considered in the context of current studies on the use of hydroxychloroquine for COVID-19, our results suggest that the drug may have an important role to play in reducing COVID-19 mortality.” Read "Hydroxychloroquine: An Open Letter to the Community & Beyond" here The study also found those treated with azithromycin alone or a combination of hydroxychloroquine and azithromycin also fared slightly better than those not treated with the drugs, according to the Henry Ford data. The analysis found 22.4% of those treated only with azithromycin died, and 20.1% treated with a combination of azithromycin and hydroxychloroquine died, compared to 26.4% of patients dying who were not treated with either medication. "Our analysis shows that using hydroxychloroquine helped save lives,” said neurosurgeon Dr. Steven Kalkanis, CEO, Henry Ford Medical Group and Senior Vice President and Chief Academic Officer of Henry Ford Health System. "As doctors and scientists, we look to the data for insight. And the data here is clear that there was benefit to using the drug as a treatment for sick, hospitalized patients.” https://www.henryford.com/news/2020/07/hydro-treatment-study We're still doing this huh? Small non-randomized study where the HCT group received much more steroids (something we know actually works in COVID patients) that goes against the findings of several larger randomized more well designed studies that showed zero benefit. Here's the Oxford Recovery Trial: https://www.nejm.org/doi/full/10.1056/NEJMoa2022926 Quote CONCLUSIONS Among patients hospitalized with Covid-19, those who received hydroxychloroquine did not have a lower incidence of death at 28 days than those who received usual care. (Funded by UK Research and Innovation and National Institute for Health Research and others; RECOVERY ISRCTN number, ISRCTN50189673. opens in new tab; ClinicalTrials.gov number, NCT04381936. opens in new tab.) Here's another randomized study from a pretty prominent infectious disease doctor out of Minnesota on post exposure prophylaxis https://www.nejm.org/doi/full/10.1056/NEJMoa2016638 Quote CONCLUSIONS After high-risk or moderate-risk exposure to Covid-19, hydroxychloroquine did not prevent illness compatible with Covid-19 or confirmed infection when used as postexposure prophylaxis within 4 days after exposure. (Funded by David Baszucki and Jan Ellison Baszucki and others; ClinicalTrials.gov number, NCT04308668. opens in new tab.) Here's another randomized one out of Barcelona. results have not been published yet but the designer has come out and said there is no difference https://clinicaltrials.gov/ct2/show/NCT04304053 Here's the WHO SOLIDARITY trial https://www.nejm.org/doi/full/10.1056/NEJMoa2023184 Quote CONCLUSIONS These remdesivir, hydroxychloroquine, lopinavir, and interferon regimens had little or no effect on hospitalized patients with Covid-19, as indicated by overall mortality, initiation of ventilation, and duration of hospital stay. (Funded by the World Health Organization; ISRCTN Registry number, ISRCTN83971151. opens in new tab; ClinicalTrials.gov number, NCT04315948. opens in new tab.) Here's the NIH ORCHID trial Quote The Outcomes Related to COVID-19 Treated with Hydroxychloroquine among In-patients with Symptomatic Disease (ORCHID) trial stopped enrolling new patients based on the fourth scheduled interim analysis showing no evidence of benefit or harm. The ORCHID trial enrolled 479 adult patients hospitalized with COVID-19 in 11 weeks at 34 hospitals in the United States. It was a multicenter, blinded, placebo-controlled randomized trial, which is the most rigorous study design to evaluate the effects of a medication. In addition to usual medical care for COVID-19, patients in the trial were treated with either 5 days of hydroxychloroquine or a placebo pill that did not have medication in it. Patients, treating clinicians, and researchers were all "blinded,” meaning that they did not know whether a given patient was receiving hydroxychloroquine or placebo. Preliminary results suggested that hydroxychloroquine was neither beneficial nor harmful for patients with COVID-19. A full analysis of trial results is ongoing and will be submitted for peer review as soon as possible. "We rapidly conducted a high-quality study to understand if hydroxychloroquine helps patients hospitalized with COVID-19,” said Wesley H. Self, MD, an emergency physician at Vanderbilt University Medical Center and lead investigator for ORCHID. "These results provide a high level of certainty that hydroxychloroquine is not a useful treatment for adults admitted to the hospital with COVID-19.” But sure, maybe a Fing observational study out of the second largest health system in Southern Michigan (that has since been quietly scrapped by the researchers BTW) knows better. This is bordering on "vaccines cause autism" territory at this point. Grow up.
March 7, 20214 yr 15 minutes ago, Dawkins 20 said: Not gonna lie, burning masks looks pretty satisfying right about now. I'm not one to be like "OMG I GOTTA GET THIS MASK OFF" the second I step outside...... ....But after my flight to (and from) Floridia, I was like "OMG I GOTTA GET THIS MASK OFF" as soon as I stepped outside because being stuck in a plane for 3 hours with both a cloth mask an an N95 mask ****' sucks.
March 7, 20214 yr 25 minutes ago, Dawkins 20 said: Not gonna lie, burning masks looks pretty satisfying right about now. I won't miss the walk of shame when I get to the front door of a store and realize I forgot my mask in the car.
March 7, 20214 yr 28 minutes ago, rambo said: I won't miss the walk of shame when I get to the front door of a store and realize I forgot my mask in the car. Every damn time.
March 7, 20214 yr 51 minutes ago, rambo said: I won't miss the walk of shame when I get to the front door of a store and realize I forgot my mask in the car. Any "Oh s*** I forgot my mask" dreams yet?
March 7, 20214 yr 2 hours ago, paco said: I'm not one to be like "OMG I GOTTA GET THIS MASK OFF" the second I step outside...... ....But after my flight to (and from) Floridia, I was like "OMG I GOTTA GET THIS MASK OFF" as soon as I stepped outside because being stuck in a plane for 3 hours with both a cloth mask an an N95 mask ****' sucks. That will never change for flights, I feel bad for people that have to fly, it is a nightmare and will only get worse 4 hours ago, DEagle7 said: We're still doing this huh? The earth is flat also
March 7, 20214 yr 2 minutes ago, Joe Shades 73 said: That will never change for flights, I feel bad for people that have to fly, it is a nightmare and will only get worse The earth is flat also I mean, at least @Kz!’s shtick and trolling is funny. You are just insufferable. Do us all a favor and post less.
March 7, 20214 yr 15 minutes ago, vikas83 said: I mean, at least @Kz!’s shtick and trolling is funny. You are just insufferable. Do us all a favor and post less. What did I say that was incorrect? When have restrictions for flights been reduced? unless of course you pay extra for the privilege
March 7, 20214 yr 1 hour ago, paco said: Any "Oh s*** I forgot my mask" dreams yet? No. PBR and weed are pretty good at killing that.
Create an account or sign in to comment